Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Non-Current Assets: 2017-2020

Historic Other Non-Current Assets for Sunshine Biopharma (SBFM) over the last 4 years, with Dec 2020 value amounting to $7,590.

  • Sunshine Biopharma's Other Non-Current Assets changed negligibly% to $7,590 in Q4 2020 from the same period last year, while for Dec 2020 it was $7,590, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $7,590 for FY2020, which is negligibly% changed negligibly from last year.
  • As of FY2020, Sunshine Biopharma's Other Non-Current Assets stood at $7,590, which was down 0.00% from $7,590 recorded in FY2019.
  • In the past 5 years, Sunshine Biopharma's Other Non-Current Assets registered a high of $989,572 during FY2018, and its lowest value of $7,590 during FY2019.
  • For the 3-year period, Sunshine Biopharma's Other Non-Current Assets averaged around $334,917, with its median value being $7,590 (2020).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 1,132.50% in 2018, then tumbled by 99.23% in 2019.
  • Yearly analysis of 4 years shows Sunshine Biopharma's Other Non-Current Assets stood at $80,290 in 2017, then surged by 1,132.50% to $989,572 in 2018, then plummeted by 99.23% to $7,590 in 2019, then remained steady at $7,590 in 2020.